Clinical Features and Outcomes of Twin Pregnancies with Antiphospholipid Antibodies Positivity: A Retrospective Study
DOI: https://doi.org/10.2147/rmhp.s456226
2024-05-07
Risk Management and Healthcare Policy
Abstract:Pengzhu Huang, 1, 2, &ast Rongrong Wu, 1, 2, &ast Xin Guo, 1, 2, &ast Xiaoli Gao, 1, 2 Ye Yan, 1, 2 Cha Han, 1, 2 Fengxia Xue 1, 2 1 Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, People's Republic of China; 2 Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin Medical University General Hospital, Tianjin, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fengxia Xue; Cha Han, Department of Gynecology and Obstetrics, Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin Medical University General Hospital, Tianjin, People's Republic of China, Tel +86-22-60363769, Fax +86-22-27813550, Email ; Objective: This study aimed to evaluate the impact of twin pregnancies with antiphospholipid antibody (aPL) positivity, a rare and complex clinical condition that remains a huge challenge for management. Methods: This study enrolled twin-pregnant women at our hospital between January 2018 and August 2023. Women with and without aPL positivity were selected using propensity score matching (PSM). Clinical features and pregnancy outcomes were compared between the two groups in the PSM cohort. To analyze the effect of aPL positivity on pregnancy outcomes, multivariate logistic models were used to obtain adjusted odds ratios (aOR) with 95% confidence intervals (CI). Results: Among the 773 women with twin pregnancies, aPL positivity was found in 26 women (3.36%). In the PSM cohort, there were 24 twin-pregnant women with positive aPL, and 48 women without aPL were selected as controls. Twin-pregnant women with aPL positivity had a higher proportion of abortion (8.33% vs 0, P = 0.043), preterm birth < 34 weeks (33.33% vs 8.33%, P = 0.007) and very low birthweight (< 1500 g) (20.83% vs 4.17%, P = 0.016) than the control group. In addition, stillbirth of one fetus was observed in one twin-pregnant woman with positive aPL. Multivariate logistic regression analysis revealed that twin pregnancy with aPL positivity was associated with preterm birth < 34 weeks (aOR = 2.76, 95% CI: 0.83– 4.70, P = 0.005), very low birthweight (< 1500 g) (OR = 2.40, 95% CI: 0.18– 4.67, P = 0.034) and small for gestational age (SGA) (aOR = 1.66, 95% CI: 0.22– 3.10, P =0.024). Conclusion: Twin pregnancies with aPL positivity were correlated with obstetric complications, including abortion, preterm birth < 34 weeks and very low birthweight (< 1500 g). The detection of aPL may be of clinical significance for women with twin pregnancies and should be considered in future studies. Keywords: twin pregnancy, antiphospholipid antibody, pregnancy outcomes, propensity score matching Antiphospholipid syndrome (APS) is a thromboinflammatory disorder caused by circulating antiphospholipid antibodies (aPL) and mainly characterized by thrombotic events, pregnancy morbidity and multiple autoimmune and inflammatory complications. 1 The incidence of APS was 1 to 2 cases per 100,000 population, and the estimated prevalence of APS was 40 to 50 cases per 100,000 population. 2–4 According to the classification criteria proposed in 2006, APS is defined as the presence of at least one clinical criterion (vascular thrombosis and/or pregnancy morbidity) along with one laboratory criterion (persistently positive aPL including the presence of lupus anticoagulant (LA), anticardiolipin antibody (aCL), or anti-β2 glycoprotein-I (aβ2GPI) on two or more occasions, at least 12 weeks apart). 5 Clinically, there are two main types of APS: patients with primary APS have no clinical or laboratory evidence of another disease, and secondary APS might be correlated with systemic autoimmune diseases such as systemic lupus erythematosus (SLE), infections, malignancies, non-malignant hematologic conditions, drugs and other disorders. 6 Patients with primary APS have a poor prognosis, particularly those with a high risk of new thrombotic events and organ damage. 7 Pregnant women with primary APS have adverse obstetric outcomes, including an increased risk of preeclampsia, low birthweight at delivery, Apgar score less than 7 at 5th minute and small infants. 8 In addition to "classical" APS, aPL is also correlated with various conditions, such as aPL carriers without clinical symptoms and aPL positivity with non-criteria manifestations. 5,6 aPL can be found not only in a small percentage of the healthy population but also in clini -Abstract Truncated-
health care sciences & services,health policy & services